Skip to main content
Clinical Trials/NCT02105493
NCT02105493
Completed
Not Applicable

A Novel Approach to Reduce Radial Artery Occlusion After Trans-Radial Catheterization: Post-Procedural/Pre-Hemostasis Intra-Arterial Nitroglycerin

National Cardiovascular Center Harapan Kita Hospital Indonesia1 site in 1 country1,706 target enrollmentOctober 2013

Overview

Phase
Not Applicable
Intervention
500 microgram of Nitroglycerin
Conditions
Injury of Radial Artery
Sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Enrollment
1706
Locations
1
Primary Endpoint
Incidence of radial artery occlusion as confirmed by absence of antegrade flow in vascular high resolution ultrasound
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Trans-radial approach (TRA) has becoming popular and widely adopted over the last decade. However, radial artery occlusion (RAO) continues to be one of the limitation of trans-radial access and potentially limits the radial artery as an access site in the future. Several strategies have been used to decrease the incidence of RAO including the use of anticoagulation, maintenance of patency during hemostasis, or shortening the duration of compression. Currently, there is no data whether vasoactive pharmacological therapy such as nitroglycerin administered intra-arterially at the end of the procedure may reduce the incidence of RAO. It is hypothesized that the addition of nitroglycerin (nitric oxide donor) at the end of a TRA procedure may reduce the incidence of RAO.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
March 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Responsible Party
Principal Investigator
Principal Investigator

Surya Dharma, MD, PhD

MD, PhD

National Cardiovascular Center Harapan Kita Hospital Indonesia

Eligibility Criteria

Inclusion Criteria

  • Sequential patients undergoing trans-radial catheterization in the institution will be consented to be randomized to receive either 500 microgram nitroglycerin (Group A) or a placebo (Group B) administered intra-arterially through the sheath at the end of the procedure.

Exclusion Criteria

  • Patients with cardiogenic shock or hemodynamically unstable
  • Unable to tolerate nitrates

Arms & Interventions

500 microgram of Nitroglycerin

500 mcg nitroglycerin was given intra-arterially through the sheath at the end of a transradial procedure

Intervention: 500 microgram of Nitroglycerin

Saline 5 mL

0,9% Saline 5 mL was given intra-arterially through the sheath at the end of a transradial procedure

Intervention: Saline 5 mL

Outcomes

Primary Outcomes

Incidence of radial artery occlusion as confirmed by absence of antegrade flow in vascular high resolution ultrasound

Time Frame: One Day After the Index Procedure

Study Sites (1)

Loading locations...

Similar Trials